研究業績

2026年

原著論文

• "Molecular Homeostasis Failure and Pathological Integration: Bridging Molecular Perturbations with Disease Phenotypes"
  Nakadate K.
  Int J Mol Sci. 27, 6 (2026).

  • DOI: 10.3390/ijms27062593
• "Splenic Macrophage Activation and Disordered Heme-Iron Metabolism in a Mouse Model of Acute Hepatic Encephalopathy."
  Tadokoro K, Ito N, Terashima R, Horigome K, Kawakami K, Nakadate K.
  Int J Mol Sci. 27, 5, 2463 (2026).

  • DOI: 10.3390/ijms27052463

2025年

原著論文

• "Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications"
  Nakadate K, Ito N, Kawakami K, Yamazaki N
  Int J Mol Sci. 26, 11, 5206 (2025).

  • DOI: 10.3390/ijms26115206
• "Impact of bevacizumab preparation conditions on inline-filter blockage."
  Ogawa C, Yatabe M, Nagayama Y, Nakadate K, Adachi S, Inoue M.
  J Oncol Pharm Pract. 24, 10781552251336176 (2025).

  • DOI: doi: 10.1177/10781552251336176.
• "Induction of MASH-like pathogenesis in the Nwd1-/- mouse liver."
  Yamada S, Ogawa H, Funato M, Kato M, Nakadate K, Mizukoshi T, Kawakami K, Kobayashi R, Horii T, Hatada I, Sakakibara SI.
  Commun Biol. 8, (1), 348 (2025).

  • DOI: doi: 10.1038/s42003-025-07717-5.
• "Advances in Understanding Lipopolysaccharide-Mediated Hepatitis: Mechanisms and Pathological Features"
  Nakadate K, Saitoh H, Sakaguchi M, Miruno F, Muramatsu N, Ito N, Tadokoro K, Kawakami K
  Curr Issues Mol Biol. 47, 2, 79 (2025).

  • DOI: 10.3390/cimb47020079
• "Use of a Mouse-human Chimeric Anti-α-galactosidase A Monoclonal Antibody as a Reference for Measuring Serum Antidrug Antibody Titers in Patients with Fabry Disease"
  Tsukimura T, Kami D, Shiga T, Togawa T, Gojo S, Sakuraba H
  Mol Genet Metab. 144, 1, 109000 (2025).

  • DOI: 10.1016/j.ymgme.2024.109000